Status:
COMPLETED
The Role of Dendritic Cells in Hepatitis C Infection
Lead Sponsor:
University College, London
Collaborating Sponsors:
Schering-Plough
Conditions:
Chronic Hepatitis C Infection
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The role of the dendritic cells, the most potent antigen presenting cells, in the establishment of chronic hepatitis C is not established. The study aims to define whether the dendritic cells are affe...
Eligibility Criteria
Inclusion
- anti-HCV positive
- HCV RNA positive
Exclusion
- contraindications for antiviral treatment
- concurrent chronic viral infections
Key Trial Info
Start Date :
April 1 2002
Trial Type :
INTERVENTIONAL
End Date :
December 1 2004
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00723242
Start Date
April 1 2002
End Date
December 1 2004
Last Update
July 28 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University College Hospital
London, United Kingdom, NW1 2BU